Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-01Measurement Properties of the Walking Adaptability Ladder Test and Foot Tap Test in People With Multiple Sclerosis With Mild Disability
-
CLINICAL_TRIALS study record update · 2026-04-01ETNA-MS Device Validation Study
-
CLINICAL_TRIALS study record update · 2026-04-01Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries
-
CLINICAL_TRIALS study record update · 2026-04-01Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2
-
CLINICAL_TRIALS study record update · 2026-04-01Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-01Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-04-01Examination of Sarcopenia and Respiratory Functions in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-03-31Evaluation of Interoception, Fatigue, and Upper and Lower Extremity Functional Capacity in Multiple Sclerosis Patients With Good and Poor Sleep Quality
-
CLINICAL_TRIALS study record update · 2026-03-31Does Remotely Delivered Pilates Influence Physical and Psychological Outcomes in Individuals With Multiple Sclerosis?
-
CLINICAL_TRIALS study record update · 2026-03-31A Single-Arm, Single-Site, Single-Dose Phase 1 Study Assessing the Safety of Bryostatin in the Treatment of Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-03-31A Phase 2, Multicenter, Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector Device Versus Syringe in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-03-30SurfSubQ - A Prospective Longitudinal Multicenter Observational Study to Investigate Neurofilament Light Chain Levels and Patient Satisfaction After Subcutaneous Ocrelizumab Administration in Persons With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-03-30A Phase IIIB Multicenter, Randomized, Double-blind, Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-03-30Clinical Efficacy of a teLerehabilItation Protocol, for the Improvement of Balance in Degenerative neurOlogical Diseases
-
CLINICAL_TRIALS study record update · 2026-03-30Virtual Reality for Gait Training in Multiple Sclerosis (VIRTUE): an Interventional Feasibility Study
-
CLINICAL_TRIALS study record update · 2026-03-30Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years
-
CLINICAL_TRIALS study record update · 2026-03-30An Open-Label Study to Assess the Safety and Efficacy of GC012F in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-03-30Examining the Utility of GLP-1 Agonists as Neuroprotective Agents Through a Pilot Clinical Trial in High Risk Population With Neurocognitive Deficits and Obesity
-
CLINICAL_TRIALS study record update · 2026-03-30Digital Cognitive Behavior Therapy for Insomnia Compared With Digital Patient Education About Insomnia in People With Multiple Sclerosis in Norway
-
CLINICAL_TRIALS study record update · 2026-03-30Effects of Mat and Reformer Pilates Training on Postural Adjustments, Balance, and Walking in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-03-30A Multiple-center, Non-randomized, Open-label, Adaptive, Single-ascending Dose (Part 1 and Part 2) and Multiple-ascending Dose (Part 3) Parallel, Phase IB Study to Investigate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of RO7121932 Following Intravenous (Parts 1) and Subcutaneous Administration (Parts 2 and 3) in Participants With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-03-30A Phase II, Randomized, Open-label, Parallel Group, Multicenter Study to Assess Bioequivalence of Two Subcutaneous Formulations of Ocrelizumab in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-03-30Skeletal Muscle Aging and Responsiveness in Aged People With MS
-
CLINICAL_TRIALS study record update · 2026-03-27A Phase IV, Prospective, Multicenter, Open-label, Mother-milk Study to Evaluate Ofatumumab Concentration in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis Receiving Ofatumumab
-
CLINICAL_TRIALS study record update · 2026-03-27A Self-management Program to Prevent Falls in Ambulatory and Non-ambulatory Community Dwelling People With Multiple Sclerosis